9PS-22302-93112
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 240 / VA
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 1 — Pfizer-BioNTech
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-30
- 2021-02-02
- 2021-02-09
-
2021-02-16
Dose 2 — Pfizer-BioNTech
- 2021-02-16
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-19
- 2021-02-21
- 2021-02-23
- 2021-03-02
-
2021-03-11
Survey response — day 21, dose 2MedDRA: Eye pruritus, Headache, Nasal congestion, Seasonal allergy, Sneezing — Feeling: FairFree text: Spring allergies - headache, itchy eyes, sneezing, stuffy nose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-05-20
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2022-10-01
Survey response — 12 months, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Tested positive for COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — day 21, dose 2
Symptoms: Spring allergies - headache, itchy eyes, sneezing, stuffy nose.
Release 12 — 12 months, dose 3
Symptoms: Tested positive for COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eye pruritus | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Seasonal allergy | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release